Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial (vol 21, pg 1099, 2022)

被引：0
|
作者：
Soileau, M. J.
Aldread, J.
Budur, K.
机构：
来源：
LANCET NEUROLOGY | 2023年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E5 / E5
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of brexpiprazole in adolescents with schizophrenia: a multicountry, randomised, double-blind, placebo-controlled, phase 3 trial with an active reference
    Ward, Caroline
    Milovancevic, Milica Pejovic
    Kohegyi, Eva
    Hefting, Nanco
    Aurang, Catherine
    Chen, Dalei
    Larsen, Klaus Groes
    Hobart, Mary
    Correll, Christoph U.
    LANCET PSYCHIATRY, 2025, 12 (05): : 345 - 354
  • [42] Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial
    Alexandrov, Andrei, V
    Kohrmann, Martin
    Soinne, Lauri
    Tsivgoulis, Georgios
    Barreto, Andrew D.
    Demchuk, Andrew M.
    Sharma, Vijay K.
    Mikulik, Robert
    Muir, Keith W.
    Brandt, Gordon
    Alleman, John
    Grotta, James C.
    Levi, Christopher R.
    Molina, Carlos A.
    Saqqur, Maher
    Mavridis, Dimitris
    Psaltopoulou, Theodora
    Vosko, Milan
    Fiebach, Jochen B.
    Mandava, Pitchaiah
    Kent, Thomas A.
    Alexandrov, Anne W.
    Schellinger, Peter D.
    LANCET NEUROLOGY, 2019, 18 (04) : 338 - 347
  • [43] BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson's disease
    Poewe, W.
    Kieburtz, K.
    Stocchi, F.
    Oren, S.
    Yardeni, T.
    Adar, L.
    Rosenfeld, O.
    Olanow, C.
    MOVEMENT DISORDERS, 2019, 34 : S74 - S74
  • [44] Ozanimod Demonstrates Efficacy and Safety in a Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Phase 3 Trial of Relapsing Multiple Sclerosis (SUNBEAM)
    Comi, Giancarlo
    Arnold, Douglas
    Cree, Bruce
    Kappos, Ludwig
    Selmaj, Krzysztof
    Bar-Or, Amit
    Steinman, Lawrence
    Hartung, Hans-Peter
    Montalban, Xavier
    Havrdova, Eva
    Sheffield, James
    Raghupathi, Kartik
    Cohen, Jeffrey
    NEUROLOGY, 2018, 90
  • [45] Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial
    Loo, Colleen
    Glozier, Nick
    Barton, David
    Baune, Bernhard T.
    Mills, Natalie T.
    Fitzgerald, Paul
    Glue, Paul
    Sarma, Shanthi
    Galvez-Ortiz, Veronica
    Hadzi-Pavlovic, Dusan
    Alonzo, Angelo
    Dong, Vanessa
    Martin, Donel
    Nikolin, Stevan
    Mitchell, Philip B.
    Berk, Michael
    Carter, Gregory
    Hackett, Maree
    Leyden, John
    Hood, Sean
    Somogyi, Andrew A.
    Lapidus, Kyle
    Stratton, Elizabeth
    Gainsford, Kirsten
    Garg, Deepak
    Thornton, Nicollette L. R.
    Fourrier, Celia
    Richardson, Karyn
    Rozakis, Demi
    Scaria, Anish
    Mihalopoulos, Cathrine
    Chatterton, Mary Lou
    McDonald, William M.
    Boyce, Philip
    Holtzheimer, Paul E.
    Kozel, F. Andrew
    Riva-Posse, Patricio
    Rodgers, Anthony
    BRITISH JOURNAL OF PSYCHIATRY, 2023, 223 (06) : 533 - 541
  • [46] The BouNDless Study: An Active-Controlled, Randomized, Double-Blind, Double-Dummy Phase 3 Study of Continuous ND0612 Infusion in Patients with Parkinson's Disease Experiencing Motor Fluctuations
    Espay, Alberto
    Rascol, Olivier
    Yardeni, Tamar
    Adar, Liat
    Rosenfeld, Olivia
    Case, Ryan
    Olanow, C. Warren
    NEUROLOGY, 2020, 94 (15)
  • [47] Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
    Xu, Jie
    Wang, Yilong
    Wang, Anxin
    Gao, Zhiqiang
    Gao, Xiaoping
    Chen, Huisheng
    Zhou, Junshan
    Zhao, Xingquan
    Wang, Yongjun
    STROKE AND VASCULAR NEUROLOGY, 2019, 4 (03) : 109 - 114
  • [48] Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis
    Oh, Jung-Hwan
    Kim, Hyun-Soo
    Cheung, Dae Young
    Lee, Hang Lak
    Lee, Dong Ho
    Kim, Gwang Ha
    Choi, Suck Chei
    Cho, Yu Kyung
    Chung, Woo Chul
    Kim, Ji Won
    Yu, Eunju
    Kwon, Hyesoo
    Kim, Jun
    Kim, John
    Jung, Hwoon-Yong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (02) : 353 - 361
  • [49] Presentation: Efficacy and Safety of Apomorphine Sublingual Film for the Treatment of "OFF" Episodes in Patients with Parkinson's Disease: A Phase 3, Double-Blind, Placebo-Controlled Trial
    Factor, S. A.
    Isaacson, S.
    Hauser, R. A.
    Pahwa, R.
    Sciarappa, K.
    Bhargava, P.
    Vakili, G.
    Blum, D.
    Navia, B.
    Olanow, C. W.
    MOVEMENT DISORDERS, 2019, 34 : S1 - S1
  • [50] A double-blind, randomised, placebo-controlled trial to investigate the efficacy and safety of nebicapone in levodopa-treated Parkinson's disease patients with motor fluctuations
    Ferreira, J. J.
    Rascol, O.
    Poewe, W.
    Sampaio, C.
    Rocha, F.
    Nunes, T.
    Almeida, L.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2008, 23 (01) : S195 - S195
12345